# Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

> **NCT00450749** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 10 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate
- Stage I Prostate Cancer
- Stage II Prostate Cancer
- Stage III Prostate Cancer

## Interventions

- **OTHER:** placebo
- **PROCEDURE:** therapeutic conventional surgery
- **OTHER:** laboratory biomarker analysis
- **DRUG:** lycopene

## Key facts

- **NCT ID:** NCT00450749
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00450749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00450749, "Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00450749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*